Levobunolol Hydrochloride

CHEMBL1201177 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

327.8 g/mol

LogP

—

Phase

4

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

Peso Molecular

327,8000 g/mol

TPSA

58,60 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl

InChI

InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1

Molecular Formula

C17H26ClNO3

HBD / HBA

3 / 4

Ligações Rotacionáveis

6

Átomos Pesados

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

Yes, Levobunolol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201177. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5284409. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Levobunolol Hydrochloride no PillFYI

Estrutura

Dados Rápidos

Fórmula: C17H26ClNO3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.